Clinical Trials in Tennessee

Showing 4921-4940 of 15,329 trials

A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies

NCT01705483

The purpose of this study is to determine the safety and tolerability and pharmacokinetics of ASP9853 combined with docetaxel or with paclitaxel in subjects with advanced non-hematologic malignancies.

Pharmacokinetics of ASP9853Non-hematologic Malignancies

Astellas Pharma Global Development, Inc.21 participantsStarted Aug 2012

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Detroit, Michigan, United States +1 more locations

RECRUITINGPhase 2/329 miles

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

NCT05254171

The study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have received prior neoadjuvant or adjuvant treatment.

Pancreatic Cancer MetastaticPancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IV

Panbela Therapeutics, Inc.600 participantsStarted Aug 2022

Hot Springs, Arkansas, United States • Fullerton, California, United States • New Haven, Connecticut, United States +90 more locations

A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

Find Trials by Condition in Tennessee

A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1

A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors

Preemie Hypothermia for Neonatal Encephalopathy

Vaginal Photobiomodulation for Chronic Pelvic Pain

A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

North American Prodromal Synucleinopathy Consortium

Memory Retrieval and Encoding Investigated by Neural Stimulation

Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients

A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies

Temozolomide (TMZ) in Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)

ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer